Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Becquemont

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Pharmacogenomics|June 18, 2009
Pharmacogenomics of adverse drug reactions: practical applications and perspectivesLaurent Becquemont
Therapie|March 1, 2017
Type 1 Gaucher disease (CYP2D6-eliglustat)Laurent Becquemont
Therapie|February 13, 2017
Laurent Becquemont
Pharmacogenomics|March 19, 2010
HLA: a pharmacogenomics success storyLaurent Becquemont
European Journal of Clinical Pharmacology|September 2, 2008
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practiceLaurent Becquemont
Therapie|June 26, 2003
[Drug interactions with antilipemics]Laurent Becquemont
Drug Metabolism Reviews|January 7, 2004
Clinical relevance of pharmacogeneticsLaurent Becquemont
Pharmacogenomics|October 12, 2017
HLA-associated drug hypersensitivity and the prediction of adverse drug reactionsSimone Negrini, Laurent Becquemont
Therapie|February 7, 2017
Pharmacogenetics of hypersensitivity drug reactionsSimone Negrini, Laurent Becquemont
Therapie|June 14, 2014
Sirolimus-related systemic thrombotic microangiopathy after renal transplantationSimone Negrini, Antoine Durrbach, Laurent Becquemont
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Pharmacogenomics|June 18, 2009
Pharmacogenomics of adverse drug reactions: practical applications and perspectivesLaurent Becquemont
Therapie|March 1, 2017
Type 1 Gaucher disease (CYP2D6-eliglustat)Laurent Becquemont
Therapie|February 13, 2017
Laurent Becquemont
Pharmacogenomics|March 19, 2010
HLA: a pharmacogenomics success storyLaurent Becquemont
European Journal of Clinical Pharmacology|September 2, 2008
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practiceLaurent Becquemont
Therapie|June 26, 2003
[Drug interactions with antilipemics]Laurent Becquemont
Drug Metabolism Reviews|January 7, 2004
Clinical relevance of pharmacogeneticsLaurent Becquemont
Pharmacogenomics|October 12, 2017
HLA-associated drug hypersensitivity and the prediction of adverse drug reactionsSimone Negrini, Laurent Becquemont
Therapie|February 7, 2017
Pharmacogenetics of hypersensitivity drug reactionsSimone Negrini, Laurent Becquemont
Therapie|June 14, 2014
Sirolimus-related systemic thrombotic microangiopathy after renal transplantationSimone Negrini, Antoine Durrbach, Laurent Becquemont
Pageof 16